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Abstract
 
The physiologic role of L-selectin shedding is unknown. Here, we investigate the effect of
L-selectin shedding on firm adhesion and transmigration. In a tumor necrosis factor 
 
a
 
–induced
model of inflammation, inhibition of L-selectin shedding significantly increased firm adhesion
and transmigration by a lymphocyte function–associated antigen (LFA)-1 and intercellular ad-
hesion molecule (ICAM)-1–dependent mechanism. We examined the quality of leukocyte
rolling and L-selectin–mediated signaling. Blockade of L-selectin shedding significantly re-
duced the “jerkiness” of leukocyte rolling, defined as the variability of velocity over time. A
low level of jerkiness was also observed in the rolling of microbeads conjugated with L-selec-
tin, a model system lacking the mechanism for L-selectin shedding. Inhibition of L-selectin
shedding potentiated activation of LFA-1 and Mac-1 induced by L-selectin cross-linking as
shown by activation epitope expression and binding of ICAM-1–conjugated beads. We con-
clude that inhibition of L-selectin shedding increases leukocyte adhesion and transmigration by
(a) increasing leukocyte exposure to the inflamed endothelium by decreasing jerkiness and (b)
promoting leukocyte activation by outside-in signaling. These observations help to resolve the
apparent discrepancy between the minor contribution of L-selectin to rolling and the signifi-
cant leukocyte recruitment defect in L-selectin knockout mice.
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Introduction
 
Leukocyte rolling, the initial step in the recruitment of
leukocytes to sites of acute inflammation, is followed
by leukocyte activation, firm adhesion, and transmigration
into the interstitial tissue (1). L-selectin contributes to
physiologic leukocyte rolling (2) and is rapidly shed from
the surface of leukocytes upon activation (3). TNF-
 
a
 
 con-
verting enzyme is involved in PMA-induced shedding of
L-selectin in murine fetal thymocytes (4); however, the
L-selectin sheddase on granulocytes has not yet been iden-
tified. Recently, we identified shedding of L-selectin as an
influential regulator of leukocyte rolling velocity (5), con-
sistent with previous in vitro data (6).
Several lines of evidence show that L-selectin–ligand in-
teractions lead to activation of leukocytes (7–10). Cross-
linking of L-selectin initiates signaling through the Ras
pathway via src-like tyrosine kinases and the small G protein
Rac (11, 12) and also causes L-selectin shedding (13). Al-
though L-selectin shedding modulates physiologic leuko-
cyte rolling velocity, it remains unknown whether L-selec-
tin shedding influences other functions such as L-selectin–
dependent signaling or leukocyte recruitment.
Chemokines such as IL-8, chemoattractants (
 
N
 
-formyl-
methionine leucylphenylalanine, platelet activating factor
[PAF]) (3), and some nonsteroidal antiinflammatory drugs
(14) are known to induce L-selectin shedding. Tissue inhib-
itor of metalloproteinase 3 (15), morphine (16), and hydrox-
amic acid derivatives (Ro31-9790 [17], KD-IX-73-4 [18])
inhibit shedding of L-selectin, presumably by inhibition of
the shedding protease. Glucocorticoids, such as dexametha-
sone, reduce PAF-induced shedding of L-selectin (19).
In vitro, L-selectin and immobilized intercellular adhe-
sion molecule (ICAM)
 
1
 
-1 synergize for the transition of
rolling lymphocytes to firm adhesion in the presence of
chemokines (20). This is corroborated by in vivo data
showing a synergistic role of L-selectin and ICAM-1 in
leukocyte rolling (21). Ligation and cross-linking of L-selec-
tin result in 
 
b
 
2
 
-integrin–dependent adhesion (7, 9, 10);
however, the role of L-selectin shedding in this process has
not been explored.
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L-Selectin Shedding Regulates Leukocyte Recruitment
 
This study aims to elucidate the role of L-selectin shed-
ding in leukocyte recruitment in vivo. To address potential
mechanisms, we investigate the change in the quality of
leukocyte rolling with blockade of L-selectin shedding by
measuring the “jerkiness” of rolling, defined as the variabil-
ity of velocity over time. We present evidence for two
complementary mechanisms that could explain the impact
of L-selectin shedding on leukocyte activation and recruit-
ment: (1) increased leukocyte exposure to the endothelium
caused by decreased rolling velocity, increased rolling flux,
and decreased jerkiness; and (2) enhanced L-selectin–medi-
ated signaling after blockade of L-selectin shedding, result-
ing in upregulation of 
 
b
 
2
 
-integrin expression and function.
 
Materials and Methods
 
Reagents.
 
KD-IX-73-4 (INH-3850-PI) and the related hy-
droxamic acid–based compound SI (PCS-3999-PI) were pur-
chased from Peptides International and were dissolved in 10 mg/
ml DMSO and diluted with saline to 1 
 
m
 
g:1 
 
m
 
l. 150 
 
m
 
g of KD-
IX-73-4 was injected into the jugular vein of mice for an esti-
mated initial serum concentration of 50 
 
m
 
g/ml.
 
mAbs.
 
mAb CBRM1/5 (22) was a gift of Dr. T.A. Springer
(Harvard Medical School, Boston, MA). mAb RB40.34 (rat
IgG1, 30 
 
m
 
g/mouse) blocks murine P-selectin and was purified
from hybridoma supernatant (a gift of Dr. D. Vestweber, Univer-
sity of Münster, Münster, Germany) (23). mAb 9A9 (rat IgG1, 30
 
m
 
g/mouse) blocks murine E-selectin (24) (a gift of Dr. B.
Wolitzky, MitoKor, San Diego, CA). The L-selectin mAb MEL-
14 (rat IgG2a, 30 
 
m
 
g/mouse) was purified from hybridoma super-
natant (American Type Culture Collection). TNF-
 
a
 
 (0.5 
 
m
 
g/
mouse) was obtained from Genzyme. Purified anti–mouse
CD11a (M17/4/01840D) and CD18 (GAME-46/28040D) were
purchased from BD PharMingen.
 
Animals.
 
8–10-wk-old male mice, 22–24 g, including wild-
type (wt) C57BL/6 (Hilltop) and mice deficient in E-selectin
(E
 
2
 
/
 
2
 
; reference 25) or L-selectin (L
 
2
 
/
 
2
 
; reference 26), E- and
P-selectin (EP
 
2
 
/
 
2
 
; reference 25), E-, P-, and L-selectin (EPL
 
2
 
/
 
2
 
;
reference 26a), and E-, P-selectin, and ICAM-1 (EPI
 
2
 
/
 
2
 
; refer-
ence 27) were used. Gene-targeted mice were backcrossed into a
C57BL/6 background for at least seven generations.
 
Anesthesia and Surgery.
 
Mice were anesthetized with keta-
mine hydrochloride (100 mg/kg, Ketalar; Parke-Davis) after pre-
treatment with xylazine (10 mg/kg intraperitoneally; Phoenix
Scientific, Inc.) and atropine sulfate (0.2 mg/kg intraperitoneally;
Elkins-Sinn) and kept at 37
 
8
 
C with a water mattress. Some mice
were pretreated for 3 or 6 h with an intrascrotal injection of 0.5
 
m
 
g murine TNF-
 
a
 
 (Genzyme) in 0.3 ml of saline.
 
Conjugated Microspheres.
 
Carboxylated fluorescent (18338)
and nonfluorescent (23526) 2-
 
m
 
m microspheres (Polysciences,
Inc.) were covalently conjugated to protein G (P-4689; Sigma-
Aldrich) using a carbodiimide coupling kit (19539; Polysciences,
Inc.). 20 
 
m
 
l of these microspheres was incubated with 5 
 
m
 
g of
murine Fc-L-selectin constructs or Fc-CD4 (28) (both gifts from
Dr. S.R. Watson, NeXstar Pharmaceuticals, Boulder, CO) for 15
min at 37
 
8
 
C. Some L-selectin–conjugated beads were incubated
with mAb MEL-14 for 30 min at 37
 
8
 
C. Recombinant human
ICAM-1 (R&D Systems) was coated to the beads at 0.1 mg/ml
and 4
 
8
 
C overnight. All microspheres were washed in PBS with
10% FBS before use in vivo.
 
Intravital Microscopy.
 
Microscopic observations were made on
an axioscope (ZEISS) with a saline immersion objective (SW 40/
0.75 numerical aperture) with modifications for stroboscopic epi-
fluorescence microscopy (60/s, Strobex 236; Chadwick Hel-
muth). Venules were observed 90–120 s for velocities of rolling
cells and numbers of adherent leukocytes, defined as cells remain-
ing stationary for 30 s or longer. Images were obtained with a
CCD camera (VE-1000CD; Dage-MTI) and recorded on S-VHS.
Distances and vessel dimensions were measured using a digital-
image processing system. Each rolling leukocyte passing a line
perpendicular to the vessel wall was followed for 0.5–1 s. Leuko-
cyte rolling velocities were calculated by dividing the traveled
distance by the tracking time. The movements of individual roll-
ing leukocytes were monitored by freeze-frame advancing. The
variability of the rolling velocity (acceleration/deceleration) was
calculated at 0.1 s intervals to quantify the jerkiness of leukocyte
rolling. Mean jerkiness values (
 
J
 
m
 
), as shown in Table I, were cal-
culated as below, 
 
D
 
x
 
 being the displacement of a cell, 
 
D
 
t
 
 the time
interval, and
 
 n 
 
the number of measurements:
Centerline blood velocities were measured by a dual photo-
diode connected to a cross-correlation program (Circusoft Instru-
mentation). Mean blood flow velocities were calculated by multi-
plying centerline velocities with 0.625 (29). Wall shear rate (
 
g
 
w
 
)
equals 2.12 
 
3
 
 8V
 
b
 
/d, where V
 
b
 
 is the mean blood flow velocity,
d, the vessel diameter, and 2.12, a median empirical factor (30).
The critical velocity (V
 
crit
 
) equals V
 
b 
 
3
 
 
 
e
 
 
 
3
 
 (2 
 
2 e
 
), where 
 
e
 
 is
the ratio of cell to vessel diameter (31).
 
Flow Cytometry.
 
Mouse peripheral blood was stained with
PE-conjugated anti–L-selectin mAb MEL-14 (01265B; BD
PharMingen), anti-CD11b mAb M1/70 (01715B; BD PharMin-
gen), or isotype control (rat IgG
 
2
 
a
 
k
 
, 11025A; BD PharMingen), 2
 
m
 
l/ml at 37
 
8
 
C for 15 min. After lysis of the erythrocytes (0.15 M
NH
 
4
 
Cl, 0.01 M NaHCO
 
3
 
, and 0.001 M disodium EDTA), cells
were washed with phosphate buffered saline containing 10% FBS
and fixed in 1% paraformaldehyde/PBS, and 10
 
4
 
 cells/sample
were analyzed by flow cytometry on a FACScan™ (Becton
Dickinson). The results reported are for granulocytes, gated by
their characteristic forward and side scatter. For analysis of
L-selectin (CD62L) and Mac-1 (CD11b) expression on human
polymorphonuclear granulocytes (PMNs), PE-conjugated mAbs
(DREG56, 32235X; ICRF44, 30455X; BD PharMingen) were
used in whole blood, followed by RBC lysis. For unlabeled pri-
mary mAbs, a FITC-labeled secondary mAb (goat anti–mouse
[GAM] or goat anti–rat [GAR]) was used. For quantitative analy-
sis of L-selectin chimeras on the surface of the microbeads, the
flow cytometer was calibrated using the Quantum Simply Cellu-
lar kit (FCSC 815; Fishers) in combination with the provided
software (QuickCal) for regression analysis.
 
Cross-Linking.
 
F(ab
 
9
 
)
 
2
 
 fragments of mAb DREG200 were
prepared by digestion with ficin (ImmunoPure IgG1 Fab and
F(ab
 
9
 
)
 
2
 
 kit 44880; Pierce Chemical Co.). F(ab
 
9
 
)
 
2
 
 fragments of
mAb MEL-14 were prepared by digestion with immobilized pep-
sin (ImmunoPure F[ab
 
9
 
]
 
2
 
 kit 44888; Pierce Chemical Co.). Di-
gests were purified from undigested mAbs and Fc fragments by
passage over protein A Sepharose columns. Neutrophils were in-
cubated with a saturating concentration of the F(ab
 
9
 
)
 
2
 
 fragments
for 15 min at 37
 
8
 
C. Cells were washed with PBS to remove un-
bound F(ab
 
9
 
)
 
2
 
 fragments and subsequently incubated with second-
ary GAM F(ab
 
9
 
)
 
2
 
 fragments (115-006-006; Jackson ImmunoRe-
search Laboratories) for cross-linking of DREG200 F(ab
 
9
 
)
 
2
 
fragments or with secondary GAR F(ab
 
9
 
)
 
2
 
 fragments (Mouse ads.,
Jm
Dxi
Dt
2 --------
i 1 =
n
å
n
------------------- = 
865
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CLCC40100; Cedarlane Laboratory Ltd.) for cross-linking of
MEL-14 F(ab
 
9
 
)
 
2
 
 fragments at 37
 
8
 
C for 30 min. Fucoidin was used
at a concentration of 20 
 
m
 
g/ml (F-5631; Sigma-Aldrich). In some
experiments, cross-linking of the PE-conjugated mAb DREG56
was achieved by addition of secondary GAM F(ab
 
9
 
)
 
2
 
 fragments.
 
Statistics.
 
Rolling velocity, jerkiness, and number of adherent
leukocytes from the same vessels before and after treatment were
compared using two-tailed paired Student’s 
 
t
 
 test for differences
in mean, since the source populations from which these data were
randomly drawn passed the tests for normal distribution. All sta-
tistical tests were performed using SigmaStat software. Statistical
significance was set at
 
 P 
 
,
 
 0.05 or
 
 P 
 
,
 
 0.01 as indicated.
 
Results
 
L-Selectin Shedding Regulates Inflammatory Leukocyte Re-
cruitment.
 
To explore the role of L-selectin shedding in
leukocyte recruitment, we chose a well characterized
model of inflammation induced by TNF-
 
a
 
 in wt (2) and
EP
 
2
 
/
 
2
 
 mice (32). In TNF-
 
a
 
–treated EP
 
2
 
/
 
2
 
 mice, where
leukocyte rolling is predominantly mediated by L-selectin
and its endothelial ligands, blockade of L-selectin shedding
with KD-IX-73-4 caused a 63% reduction in rolling veloc-
ity (Fig. 1). To explore this change in rolling, we examined
jerkiness, measured as acceleration/deceleration of rolling
cells at 0.1 s intervals. Jerkiness was dramatically reduced in
both untreated wt mice (Fig. 2 B) and TNF-
 
a
 
–treated
EP
 
2/2
 
 mice (Fig. 2 D) after blocking shedding. The veloc-
ity profiles (Fig. 2 A) underlying the jerkiness calculations
show that physiologically rolling cells can temporarily
travel above the critical velocity. This does not occur after
blockade of shedding (Fig. 2 A) or when E-selectin is ex-
pressed (data not shown). However, in L
 
2/2
 
 and EPL
 
2
 
/
 
2
 
mice jerkiness remained unchanged after application of
KD-IX-73-4, showing that the effect of KD-IX-73-4 is
specifically mediated by L-selectin (Table I). To address
why blockade of L-selectin shedding does not affect leuko-
cyte rolling velocity when E-selectin is expressed (5), we
measured the jerkiness in 3-h TNF-
 
a
 
–treated wt and E
 
2
 
/
 
2
 
mice. Jerkiness in TNF-
 
a
 
–treated wt mice (Table I) was
Figure 1. Leukocyte rolling velocities and L-selectin expression. Cu-
mulative frequency of velocities of rolling leukocytes in wt and EP2/2
mice with or without TNF-a treatment. wt data are shown for clarity and
comparison from (reference 5). Significant reduction in rolling velocity in
EP2/2 with TNF-a treatment. s, before the blockade of L-selectin shed-
ding; d, 1–10 min after the blockade of L-selectin shedding. P , 0.01.
Figure 2. Impact of L-selectin shedding on jerkiness of
rolling. (A) Velocity profiles of three representative rolling
leukocytes measured at 0.1 s intervals in untreated wt mice
before (left) and after (right) the blockade of L-selectin
shedding. Dotted line, critical rolling velocity. (B) Jerkiness
(variability of velocity) of 10 rolling leukocytes over 0.1-s
intervals before (left) and after (right) the blockade of L-selec-
tin shedding in wt mice. (C) Jerkiness of 10 rolling leuko-
cytes over 0.1 s intervals in TNF-a–treated wt mice before
(left) and after (right) blockade of L-selectin shedding with
KD-IX-73-4. (D) Jerkiness of 10 rolling leukocytes before
(left) and after (right) the blockade of L-selectin shedding in
TNF-a–treated EP2/2 mice. Arrows, values of the data
points outside of the panel.866 L-Selectin Shedding Regulates Leukocyte Recruitment
unaffected by the blockade of L-selectin shedding (Fig. 2
C); however, in E2/2 mice jerkiness was significantly re-
duced after blockade of L-selectin shedding (Table I).
When L-selectin was blocked with mAb MEL-14 in TNF-
a–treated E2/2 mice, jerkiness was reduced by 19.7% (30
cells from seven venules in two mice; P , 0.05). These
data suggest that L-selectin shedding regulates jerkiness of
rolling and that jerkiness of rolling on E-selectin is so low
that inhibition of L-selectin shedding is of no further con-
sequence to the jerkiness or to the rolling velocity. Blood
pressure, centerline velocities, diameters, shear rates of the
observed venules, and the systemic leukocyte counts were
unaffected by the application of KD-IX-73-4 (Table II,
some data not shown).
To model the interaction of leukocytes after the block-
ade of L-selectin shedding, we constructed L-selectin–con-
jugated microspheres that lacked the machinery needed to
shed L-selectin. The copy number of L-selectin chimera
was quantified at z5.8 3 104/bead by comparison with the
Ab binding capacity of calibrated beads in flow cytometry
(Fig. 3 C). However, even though the copy number of
L-selectin on these microspheres is in the same order of
magnitude as on leukocytes, its relation to physiologic site
densities on leukocyte microvilli is unclear. These micro-
spheres rolled at a low jerkiness on TNF-a–treated
cremaster microvenules of wt mice (Fig. 3, A and B), simi-
lar to KD-IX-73-4–treated leukocytes (Fig. 2 C), although
at a higher velocity (Table I). Incubation of the micro-
spheres with function blocking mAb MEL-14 significantly
reduced the average interaction of the microspheres with
the endothelium from 23 6 5 to 4 6 1%. As a control,
when chimeric CD4 was conjugated instead of L-selectin,
microspheres showed 2 6 1% interaction with the endo-
thelium.
Inhibition of L-Selectin Shedding Promotes Leukocyte Adhe-
sion. We next investigated the impact of L-selectin shed-
ding on leukocyte adhesion by comparing leukocyte accu-
mulation over 10 min after application of KD-IX-73-4 or
vehicle in TNF-a–treated wt and EP2/2 mice. In TNF-a–
treated wt mice, firm adhesion significantly increased two-
fold after inhibition of shedding (P , 0.05; Fig. 4 A). In
EP2/2 mice, firm adhesion increased 2.7-fold after inhibi-
tion of shedding (P , 0.05; Fig. 4 A). Concomitant with
increased adhesion, inhibition of L-selectin shedding in-
creased the number of transmigrating cells, recognized by
their characteristic change of shape during their transendo-
thelial passage (Fig. 4 B). As a control, application of KD-
IX-73-4 in TNF-a–treated L2/2 and EPL2/2 mice did not
change firm adhesion or transmigration (Fig. 4), or decrease
rolling velocity or jerkiness (Table I, and data not shown).
Role of LFA-1 and ICAM-1. LFA-1 and Mac-1 inter-
act with ICAM-1, mediating firm leukocyte adhesion (33,
34). We therefore tested whether the increase in leukocyte
recruitment after blockade of L-selectin shedding is ICAM-1
dependent. In TNF-a–treated EPI2/2 mice, inhibition of
L-selectin shedding did not increase firm adhesion or trans-
Table I. Rolling Velocity and Jerkiness under Different Conditions
Genotype Condition
Rolling
velocity Jerkiness (Jm)
TNF-a KD-IX-73-4
 m m/s mm/s2
Wt 22 58 6 5*‡ 453 6 48‡
21 42 6 6*‡ 163  6 17‡
124.5 6 0.3 115 6 12
114.1 6 0.3 131 6 11
(Microspheres) 12 103 6 5 135 6 9
EP2/2 12 72 6 8‡ 518 6 77‡
11 30 6 2‡ 232 6 35‡
E2/2 12 24 6 1* 176 6 16‡
11 18 6 1* 117 6 9‡
L2/2 22 37 617* 274 6 60
21 38 6 15* 297 6 90
EPL2/2 12 13 6 1 207 6 27
11 14 6 1 204 6 16
Data are mean 6 SEM.
*Data from reference 5.
‡P , 0.01.
Table II. Hemodynamic Parameters before and after Injection of KD-IX-73-4
Centerline velocity Diameter Wall shear rate g
Genotype Before After Before After Before After
mm/s mms 21
Wt 2.3 6 0.3 2.4 6 0.4 37 6 2 36 6 1 661 6 42 705 6 92
EP2/2 2.7 6 0.3 2.8 6 0.3 43 6 8 45 6 9 837 6 121 891 6 206
EPI2/2 2.2 6 0.4 2.3 6 0.3 32 6 3 31 6 3 815 6 217 869 6 198
EPL2/2 2.6 6 0.1 2.7 6 0.3 23 6 1 23 6 2 1,251 6 61 1,244 6 80
Data are mean 6 SEM.867 Hafezi-Moghadam et al.
migration, suggesting ICAM-1 is necessary for L-selectin–
mediated leukocyte recruitment (Fig. 4). Functional block-
ade of CD18 with mAb GAME-46 or of LFA-1 with mAb
M17/4 also prevented the elevated recruitment after block-
ade of L-selectin shedding (Fig. 4 A). These data show that
increased leukocyte adhesion after blockade of L-selectin
shedding requires LFA-1 and ICAM-1.
L-Selectin Shedding Regulates Leukocyte Activation. Since
cross-linking L-selectin downregulates its expression (13),
activates the leukocyte, and upregulates b2-integrin expres-
sion and avidity (7–9), we hypothesized that L-selectin–
mediated activation may be self-limiting by L-selectin’s
rapid cleavage upon ligation. We reasoned that cross-link-
ing together with blockade of L-selectin shedding would
result in a higher leukocyte activation compared with
cross-linking alone. To test this hypothesis, we cross-linked
L-selectin with and without prior incubation with KD-IX-
73-4 and measured L-selectin, Mac-1 expression, the ex-
pression of a Mac-1 activation epitope recognized by mAb
CBRM1/5 (22), and the binding of these leukocytes to
ICAM-1–coated microspheres. To show that cross-link-
ing–mediated shedding of L-selectin can be blocked with
KD-IX-73-4, we added secondary F(ab9)2 fragments to hu-
man neutrophils labeled with PE-DREG56 mAb with and
without KD-IX-73-4, and measured L-selectin expression
(Fig. 5 A). Incubating leukocytes with KD-IX-73-4 alone
did not increase Mac-1 expression (Fig. 5 B). Cross-linking
L-selectin on human PMNs with F(ab9)2 fragments of mAb
DREG200 increased Mac-1 expression (Fig. 5 C). L-selec-
tin cross-linking after blockade of shedding caused a larger
increase in Mac-1 expression than cross-linking alone. In-
Figure 3. (A) Composite of eight superimposed video frames of a rep-
resentative rolling L-selectin–conjugated microsphere in vivo. Time be-
tween the first and the last frame, 0.8 s. (B) Jerkiness of 10 L-selectin–
conjugated microspheres on cytokine-stimulated endothelium of wt mice
over 0.1 s intervals. (C) Number of L-selectin molecules on microspheres.
Mean fluorescence values of calibration beads (open squares) with known
mAb binding capacity obtained in flow cytometry (filled histograms). Flu-
orescence value of PE-DREG56 mAb binding to L-selectin–conjugated
nonfluorescent beads (open histogram). Copy number of the PE-
DREG56 bound to L-selectin–conjugated microspheres based on the re-
gression line (filled circle).
Figure 4. L-selectin–mediated arrest on cytokine-stimulated endo-
thelium. (A) Bars represent mean (6 SEM) increase of adherent leuko-
cytes within 8–10 min after blockade of L-selectin shedding with KD-
IX-73-4 in various mouse genotypes, compared with adhesion in the
same venule without KD-IX-73-4. Studied number of venules/mice for
leukocyte adhesion: wt, 17/7; EP2/2, 8/4; the remaining groups, 5/2 or
higher. For CD18 and LFA-1 blockade, mAbs systemically injected be-
fore the blockade of L-selectin shedding in EP2/2 mice. Control, one-
fold increase of adhesion after vehicle in wt or EP2/2 mice within the
same time frame. *Significantly different from all other groups. P ,
0.05. (B) Representative video micrographs showing the increase of
firmly adhering and transmigrating leukocytes before and 8–10 min after
blockade of L-selectin shedding in three different gene-targeted mice.868 L-Selectin Shedding Regulates Leukocyte Recruitment
cubating leukocytes with fucoidin, a polyvalent L-selectin
ligand that cross-links L-selectin (35), increased Mac-1 ex-
pression, which was further elevated after blockade of
shedding (Fig. 5 D). To understand whether the increased
expression of Mac-1 is accompanied by conformational
activation, we used mAb CBRM1/5, which binds to the
active conformation of the I-domain (22). Human neutro-
phils bound more CBRM1/5 when L-selectin was cross-
linked by fucoidin and shedding was blocked, compared
with incubation with fucoidin alone (Fig. 5 E).
To measure the impact of L-selectin cross-linking on ad-
hesiveness of neutrophils with and without shedding, we
quantified neutrophil binding to ICAM-1–coated beads
(Fig. 6). The number of neutrophils with no bound
ICAM-1 beads decreased systematically from 30% for rest-
ing neutrophils, to 24% with L-selectin cross-linked, and to
13% when L-selectin was cross-linked and shedding
blocked. Conversely, the number of neutrophils with four
or more bound ICAM-1 beads increased from 11 to 22 to
36%, respectively. KD-IX-73-4 alone did not affect
ICAM-1 bead binding (30% for no beads, 15% for four
beads, and data not shown).
To elucidate whether the enhanced leukocyte activation
after blockade of shedding is specific for L-selectin, we
generated MEL-14 F(ab9)2 fragments against murine L-selec-
tin. Cross-linking of L-selectin on murine wt neutrophils
with MEL-14 F(ab9)2 and secondary GAR F(ab9)2 frag-
ments, with or without blockade of shedding, revealed re-
sults completely corresponding to those seen in human
neutrophils (Fig. 7). In contrast, incubation of neutrophils
from L2/2 mice with MEL-14 F(ab9)2 and secondary GAR
F(ab9)2 fragments did not change the expression of Mac-1
(Fig. 7). The Mac-1 expression also remained unchanged
if, in addition to the F(ab9)2 fragments, the shedding inhib-
itor KD-IX-73-4 was added to the neutrophils (Fig. 7).
Figure 5. Regulatory function of shedding on L-selectin–mediated
PMN activation. (A) L-selectin expression on human neutrophils with or
without cross-linking of PE-DREG56 with secondary F(ab9)2 fragments
and with or without incubation with KD-IX-73-4 (50 mg/ml at 378C for
20 min). (B–D) Mac-1 expression on human neutrophils. (B) With or
without incubation with KD-IX-73-4 (50 mg/ml at 378C for 20 min);
(C) after cross-linking with DREG200 F(ab9)2 fragments and secondary
F(ab9)2 fragments with or without incubation with KD-IX-73-4; and (D)
L-selectin ligation with fucoidin with or without incubation with KD-
IX-73-4. (E) Expression of a Mac-1 activation epitope, detected by
CBRM1/5 after L-selectin ligation with fucoidin with or without incu-
bation with KD-IX-73-4. Dotted line, unstained PMNs. Data shown is
representative of three independent experiments. KD, KD-IX-73-4.
Figure 6. Regulatory function of shedding on PMN adhesive func-
tion. Binding of ICAM-1–coated microspheres to human PMNs. (A) No
treatment. (B) L-selectin ligation with fucoidin. (C) L-selectin ligation
with fucoidin and blockade of L-selectin shedding. Peaks in each panel
from left to right, PMNs bound to 0, 1, ... n beads, respectively. Data
shown is representative of three independent experiments.869 Hafezi-Moghadam et al.
Discussion
L-selectin shedding has a surprisingly large impact on the
stages of leukocyte recruitment subsequent to rolling. Our
data suggest two mechanisms linking L-selectin shedding
with leukocyte recruitment.
Increased Leukocyte Exposure to the Endothelium When
L-Selectin Shedding Is Blocked. The velocity of rolling leuko-
cytes decreased significantly with the blockade of L-selectin
shedding. Decreased velocity increases transit time of roll-
ing leukocytes on cytokine-stimulated endothelium and
can increase the chance of activation of the leukocyte by
endothelial mediators and the likelihood for a successful ar-
rest (36). Shedding of L-selectin appears to be a regulatory
parameter that impacts the transition from rolling to firm
adhesion.
Conventionally, rolling has been understood as move-
ment below the critical velocity (31). Based on our data, a
physiologically rolling leukocyte can temporarily travel
faster than the critical velocity. The process of a rolling leu-
kocyte accelerating above the critical rolling velocity, trav-
eling transiently at a hydrodynamic velocity, and decelerat-
ing below critical velocity represents a “microjump.”
Blocking shedding decreases the jerkiness of rolling and di-
minishes microjumps. Jerkiness reflects discontinuous and
nonuniform contact between the rolling leukocyte and the
endothelium. Rolling at a lower jerkiness means fewer mi-
crojumps and longer contact time between the rolling leu-
kocyte and the endothelium. This allows the rolling leuko-
cyte to ‘scan’ the surface of the endothelial layer more
closely and sample endothelial signaling molecules, such as
chemokines. Thus, inhibition of L-selectin shedding in-
creases the exposure of a rolling leukocyte to the inflamed
endothelium by (a) increasing the transit time and (b) ele-
vating the continuous contact time with the endothelium
by diminishing the microjumps.
Enhanced Leukocyte Activation After Blockade of L-Selectin
Shedding. L-selectin’s dual function in leukocyte capture/
rolling (1) and as a signaling molecule (7–9, 11) is well es-
tablished. Cross-linking of L-selectin activates leukocytes
(7, 8) and causes its own downregulation (13). We have
shown that L-selectin is shed during rolling in vivo (5),
agreeing with previous in vitro findings (6). However, the
physiological consequences of L-selectin signaling and
shedding were previously unknown. Our present data sug-
gest that blockade of L-selectin shedding also enhances sig-
naling to the rolling leukocyte, as shown by upregulated
Mac-1 expression, increased binding to ICAM-1, and in-
creased expression of activated Mac-1. We provide direct
in vivo evidence for the importance of this mechanism by
showing that blockade of L-selectin shedding enhances leu-
kocyte adhesion in cytokine-treated wt and EP2/2 mice.
Furthermore, this adhesion is ICAM-1 and LFA-1 depen-
dent. Inhibition of L-selectin shedding without L-selectin
cross-linking does not activate the leukocyte. Since block-
ing L-selectin shedding in combination with ligand interac-
tion or cross-linking activates the cell more than ligand
interaction or cross-linking alone, we propose that engage-
ment of L-selectin during rolling results in cell signals that
enhance b2-integrin adhesive responses, which are further
increased, if shedding is blocked.
Based on the current data, both increased exposure to
the endothelium and enhanced signaling represent equally
attractive models, contributing to an unknown extent in
regulation of leukocyte recruitment. However, the fact that
in TNF-a–treated wt mice, blockade of L-selectin shed-
ding increases firm adhesion without any apparent change
to the rolling velocity or jerkiness, compared with EP2/2
mice, where an increase in firm adhesion coincides with a
reduction in rolling velocity and jerkiness, suggests that en-
hanced signaling through L-selectin after blockade of shed-
ding is critical. However, neither enhanced signaling alone
nor increased endothelial contact time alone appears to be
sufficient for leukocyte arrest in vivo. This is supported by
our finding that blockade of L-selectin shedding in un-
treated wt mice causes a reduction of rolling velocity but
does not induce arrest (5). In addition to the increased acti-
vation of the rolling leukocyte by blockade of L-selectin
shedding, activation of the endothelium, i.e., endothelial
presentation of chemokines induced by TNF-a treatment,
appears to be necessary for arrest (37, 38).
Recruitment Deficit in L2/2 Mice. Although originally
identified as a homing receptor for lymphocyte recruitment
to peripheral lymph nodes, L-selectin also plays a vital role
in leukocyte recruitment to peripheral sites of inflamma-
tion, as shown by the significant deficit in PMN recruit-
ment of L2/2 mice in many models (26, 39, 40). However,
this important role of L-selectin is not explained by the rel-
atively minor contribution of L-selectin to leukocyte roll-
Figure 7. Regulatory function of shedding on L-selectin–mediated
leukocyte activation. Mac-1 expression on neutrophils, obtained from wt
and L2/2 mice. (i)Without treatment; (ii) L-selectin cross-linked with
MEL-14 F(ab9)2 fragments plus secondary GAR F(ab9)2 fragments; and
(iii) L-selectin cross-linked with MEL-14 F(ab9)2 fragments plus second-
ary GAR F(ab9)2 fragments and blockade of L-selectin shedding. Dotted
line, unstained PMNs. Data shown is representative of three independent
experiments.870 L-Selectin Shedding Regulates Leukocyte Recruitment
ing (2, 32). Our findings provide a mechanism that may
explain the requirement for L-selectin in leukocyte recruit-
ment.
Role of CD11a/CD18 and ICAM-1 in L-Selectin–induced
Firm Adhesion. CD18-dependent arrest of neutrophils on
ICAM-1 in shear flow is induced by L-selectin ligation (9).
Our data indicate that ICAM-1 and LFA-1 are necessary
for the transition of L-selectin–mediated rolling to firm ad-
hesion on cytokine-activated endothelium in vivo, since
the increase of firm adhesion through inhibition of L-selec-
tin shedding only occurs if ICAM-1 is expressed.
Rolling of L-Selectin–conjugated Microspheres. Rolling of
these microspheres clearly indicates that, although shedding
of L-selectin is necessary for rolling at physiologic veloci-
ties, it is not required for rolling in general. The extracellu-
lar domain of L-selectin is sufficient to support L-selectin–
mediated rolling on its endothelial ligands at a comparable
low jerkiness as the rolling of leukocytes after blockade of
L-selectin shedding. The bead data also confirm previous
findings that L-selectin does not have to be expressed on
microvilli to support rolling (41).
Physiologic Relevance of Shedding. Since blockade of
shedding caused enhanced activation of leukocytes with
higher levels of recruitment in both wt and EP2/2 mice
but not in L2/2 and EPL2/2 mice, shedding of L-selectin
appears to be a physiologic mechanism to limit neutrophil
recruitment during inflammation. L-selectin ligation acti-
vates the leukocyte, but L-selectin–mediated rolling alone
is not sufficient to elevate firm adhesion and transmigra-
tion. Shedding during L-selectin ligation may be responsi-
ble for keeping the activation status of a rolling leukocyte
below the level necessary for successful arrest. By blocking
shedding, we disable this mechanism, resulting in increased
activation of the surface cross-linked cell in vitro or an in-
creased firm adhesion in vivo. This is consistent with the
finding that leukemia cells with lower expressions of L-selec-
tin show impaired transendothelial migration in vitro (42).
Some of the antiinflammatory effects of nonsteroidals (14)
may also be related to enhanced L-selectin shedding.
Previously we showed that reduction of rolling velocity
does not occur with blockade of L-selectin shedding when
E-selectin is expressed (5). Here we show that rolling on
E-selectin expressing endothelium reveals the lowest level
of jerkiness among all examined leukocyte rolling condi-
tions, which did not further decrease after blockade of
L-selectin shedding. The lack of microjumps when E-selec-
tin is expressed may explain why the velocity does not
change upon blockade of shedding. However, if only P-selec-
tin is expressed, as in cytokine-treated E2/2 mice, rolling
leukocytes perform some microjumps, which can be re-
duced by blockade of L-selectin shedding. These L-selec-
tin–independent, occasional microjumps, for instance dur-
ing P-selectin–mediated rolling or in EPL2/2 mice, may be
attributable to local variations of hydrodynamic conditions
or nonuniform expression patterns of endothelial adhesion
molecules (43).
In conclusion, our data suggest that L-selectin plays at
least two roles in the recruitment of leukocytes to periph-
eral sites of inflammation. Continuous L-selectin shedding
regulates the quality of leukocyte rolling by affecting the
jerkiness of rolling and, consequently, the close leukocyte
endothelial contact time and thus the accessibility of endo-
thelial activation signals including chemokines. In addition,
L-selectin–mediated signaling appears to activate rolling
leukocytes and to promote their arrest if other costimula-
tory signals such as endothelially presented chemokines are
expressed. Further studies will be necessary to elucidate
whether a rolling leukocyte is able to integrate signals from
chemokine receptor– and adhesion molecule–ligand inter-
actions to initiate arrest. These mechanisms probably act in
concert to promote leukocyte adhesion at sites of inflam-
mation.
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